• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Osteoplasty holds promise for repair of bone fractures

Article

Minimally invasive repair of painful vertebral compression fractures has become an established treatment for osteoporosis. The development of similar techniques to treat other fractures caused by age and metastatic disease could be a cost-effective way to deal with declining reimbursements and a growing elderly population.

Minimally invasive repair of painful vertebral compression fractures has become an established treatment for osteoporosis. The development of similar techniques to treat other fractures caused by age and metastatic disease could be a cost-effective way to deal with declining reimbursements and a growing elderly population.

Percutaneous osteoplastic techniques treating common insufficiency-type fractures affecting the pelvis, sacrum, and long bones are gaining attention. Like vertebroplasty, these techniques rely on the injection of cement or other compounds to stabilize the lesion. Some also combine the effects of thermal ablation when fractures are caused by tumors.

Researchers at the University of British Columbia have released results of a study that combined radiofrequency ablation and cement-based osteoplasty in patients with painful vertebral, acetabular, sacral, and pelvic fractures produced by tumors. Eleven patients underwent 15 combined RFA and cementoplasties with a 100% technical success rate and no major complications.

Another investigative team from Indian River Radiology in Vero Beach, FL, performed a prospective study comparing polymethylmeth­acrylate (PMMA) with a new, more malleable polymer-based injectable material for vertebroplasty (Cortoss, Orthovita). The investigators have enrolled a total of 256 patients over three years and have found Cortoss to be as effective and safe as PMMA. Both studies were presented at the 2008 Society of Interventional Radiology meeting.

Though common, insufficiency fractures are underrecognized and undertreated, said Dr. Douglas P. Beall, chief of musculoskeletal imaging at the University of Oklahoma Health Sciences Center. About 40% of women and 25% of men will have to deal with these disabling lesions during their lifetime.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.